The George Institute For Global Health
Global
United Kingdom
India
China
Australia

News and Events

For the first time ever, French-speaking physiotherapists can now access PEDro, a global resource for evidence-based physiotherapy.

Media release: 
24/11/2010

Less than half of bread products in Australian supermarkets have acceptable salt levels, according to data released today by Sydney based, The George Institute for Global Health.

Media release: 
23/11/2010

The world’s largest kidney disease trial of over 9,400 volunteers aged 40 or over with chronic kidney disease, 2,281 of whom were recruited from 64 sites in Australia, New Zealand, Malaysia and Thailand, has shown that the combination of the cholesterol-lowering drugs ezetimibe and simvastatin could reduce by a quarter all heart attacks, strokes and operations to open blocked arteries in people with chronic kidney disease.

Media release: 
17/11/2010

Three leading academics from The George Institute for Global Health have been awarded Australian Research Council ‘Future Fellowship’ grants to cover four years of work in their areas of expertise.

Media release: 
11/11/2010

Australian researchers have joined with leading academics from around the world to call for a new focus to improve systems of health in low and middle-income countries in a paper today published in the highly respected The Lancet.

Australian researchers have joined with leading academics from around the world to call for a new focus to improve systems of health in low and middle-income countries in a paper today published in the highly respected The Lancet.

Media release: 
15/10/2010

The George Institute for Global Health has been awarded just over $10 million in research grants from the National Health and Medical Research Council (NHMRC) for projects scheduled to commence in 2011.

Media release: 
11/10/2010

A new systematic review has provided much needed clarity for clinicians across the world, confirming the benefits of cholesterol medication, for patients at high risk of heart disease. The analysis, undertaken at The George Institute, showed that fibrates, a commonly used medication used to improve cholesterol and prevent heart disease, provide a 10-15% reduced risk of serious cardiovascular events, mainly due to a reduction in the risk of heart attack.

Media release: 
07/10/2010

A new study published today by Sydney-based The George Institute for Global Health has found that people with type 2 diabetes who suffer episodes of critically low blood sugar levels (severe hypoglycemia) are at greater risk of suffering subsequent vascular problems such as a heart attack, stroke and kidney disease, as well as non-vascular problems such as cancer and respiratory conditions.

Could a ‘four-in-one’ pill be an answer to a condition anticipated to kill 23.6 million people globally each year by 2020?

Pages